Novocure Inc.
Senior Medical Science Liaison, Oncology
Novocure Inc., California, Missouri, United States, 65018
The
Senior Medical Science Liaison
(MSL) role will serve as the scientific interface between Novocure and the healthcare professional communities with respect to communicating scientific information about Novocure products, scientific data, and clinical development plans. The position will be responsible for developing and maintaining relationships within the medical/scientific community and providing medical and/or scientific data about Novocure products and research to healthcare professionals. Clinical, scientific, and technical expertise will be maintained through review of scientific literature, attendance at assigned medical meetings, and self-learning. The Sr. MSL will work closely with cross-functional partners including R&D, Clinical Operations, and the Canada BU. This role will support the western Canadian region and drive GBM launch and contribute to pre-launch activities for future indications. This is a full-time, exempt, field-based role reporting to the Medical Director, CNS Cancers Canada. ESSENTIAL DUTIES AND RESPONSIBILITIES: Provide field-based medical information, scientific data, and education to HCPs on Novocure's Health Canada approved and pipeline products. Develop and maintain successful relationships with thought leaders, clinical investigators, and other providers in the scientific community. Support the Clinical Operations organization, as needed, in Novocure's sponsored research. Serve as the primary liaison with investigators interested in discussing and developing investigator-initiated research of Fields, inovitroTM, or Novocure investigational products. Ensure compliance in all scientific communications and education in disease states of interest to Novocure. Attend and provide scientific support of Canada Medical Affairs activities and scientific sessions at regional and national congress meetings. Provide Novocure with Competitive Intelligence (CI), disease treatment trends, and relevant key insights. Serve as an internal scientific resource for training and educational support. QUALIFICATIONS/KNOWLEDGE: Advanced degree with scientific/clinical background preferred. At least 3 years' experience as an MSL, or comparable role required. At least 5 years of combined oncology or industry experience required. Ability to travel up to 60% throughout Canada, with some international travel. Must have excellent verbal skills, strong presentation skills, and writing skills. Possess a proven ability to effectively communicate complex information. Must demonstrate fluency in articulating scientific concepts and data. Must have good judgment, ability to adapt and change in a shifting environment. A strategic, passionate, self-starter who takes initiative. Must work well in large and small teams, ability to work remotely. ABOUT NOVOCURE: Our vision: Patient-forward, aspiring to make a difference in cancer. Our patient-forward mission: Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy.
#J-18808-Ljbffr
Senior Medical Science Liaison
(MSL) role will serve as the scientific interface between Novocure and the healthcare professional communities with respect to communicating scientific information about Novocure products, scientific data, and clinical development plans. The position will be responsible for developing and maintaining relationships within the medical/scientific community and providing medical and/or scientific data about Novocure products and research to healthcare professionals. Clinical, scientific, and technical expertise will be maintained through review of scientific literature, attendance at assigned medical meetings, and self-learning. The Sr. MSL will work closely with cross-functional partners including R&D, Clinical Operations, and the Canada BU. This role will support the western Canadian region and drive GBM launch and contribute to pre-launch activities for future indications. This is a full-time, exempt, field-based role reporting to the Medical Director, CNS Cancers Canada. ESSENTIAL DUTIES AND RESPONSIBILITIES: Provide field-based medical information, scientific data, and education to HCPs on Novocure's Health Canada approved and pipeline products. Develop and maintain successful relationships with thought leaders, clinical investigators, and other providers in the scientific community. Support the Clinical Operations organization, as needed, in Novocure's sponsored research. Serve as the primary liaison with investigators interested in discussing and developing investigator-initiated research of Fields, inovitroTM, or Novocure investigational products. Ensure compliance in all scientific communications and education in disease states of interest to Novocure. Attend and provide scientific support of Canada Medical Affairs activities and scientific sessions at regional and national congress meetings. Provide Novocure with Competitive Intelligence (CI), disease treatment trends, and relevant key insights. Serve as an internal scientific resource for training and educational support. QUALIFICATIONS/KNOWLEDGE: Advanced degree with scientific/clinical background preferred. At least 3 years' experience as an MSL, or comparable role required. At least 5 years of combined oncology or industry experience required. Ability to travel up to 60% throughout Canada, with some international travel. Must have excellent verbal skills, strong presentation skills, and writing skills. Possess a proven ability to effectively communicate complex information. Must demonstrate fluency in articulating scientific concepts and data. Must have good judgment, ability to adapt and change in a shifting environment. A strategic, passionate, self-starter who takes initiative. Must work well in large and small teams, ability to work remotely. ABOUT NOVOCURE: Our vision: Patient-forward, aspiring to make a difference in cancer. Our patient-forward mission: Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy.
#J-18808-Ljbffr